Development and biomarkers of CD20/CD3 bispecific antibodies in diffuse large B-cell lymphoma
Journal of Clinical and Experimental Hematopathology · 2025
DOI: 10.3960/jslrt.25055 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2025. Verfasst von Chisako Iriyama. Beteiligte Einrichtung: Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Antibodies, Bispecific, CD3 Complex, Antigens, CD20. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Zitieren
APA
Iriyama, C. (2025). Development and biomarkers of CD20/CD3 bispecific antibodies in diffuse large B-cell lymphoma. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.25055
Vancouver
Iriyama C. Development and biomarkers of CD20/CD3 bispecific antibodies in diffuse large B-cell lymphoma. Journal of Clinical and Experimental Hematopathology. 2025. doi:10.3960/jslrt.25055
BibTeX
@article{Iriyama2025,
author = {Iriyama, Chisako},
title = {Development and biomarkers of CD20/CD3 bispecific antibodies in diffuse large B-cell lymphoma},
journal = {Journal of Clinical and Experimental Hematopathology},
year = {2025},
doi = {10.3960/jslrt.25055}
}
EUVIMED